Atheroclonal Consortium

The Hematovascular Pathophysiology Laboratory is focused on evaluating new mechanisms that link clonal hematopoiesis to cardiovascular and metabolic disorders, with an especial interest in context of aging. Their research combines human studies, both cross-sectional and longitudinal, to elucidate the associations between CH and cardiovascular disease, and experimental studies to provide causal evidence and mechanisms of action for the observations made in the human cohorts.